The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy

The bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current stat...

Full description

Bibliographic Details
Main Author: Patricia Méndez-Samperio
Format: Article
Language:English
Published: Pasteur Institute of Iran 2019-06-01
Series:Vaccine Research
Subjects:
bcg
global health
clinical trials
tuberculosis
vaccine
Online Access:http://vacres.pasteur.ac.ir/article-1-166-en.html

Internet

http://vacres.pasteur.ac.ir/article-1-166-en.html

Similar Items